Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Cholangiocarcinoma × pazopanib × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 22 Sarcoma 17 Neoplasms 8 Breast Neoplasms 8 Neoplasm Metastasis 7 Ovarian Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Hemangiosarcoma 5 Fallopian Tube Neoplasms 5 Lung Neoplasms 4 Liposarcoma 4 Leiomyosarcoma 4 Kidney Neoplasms 4 Urinary Bladder Neoplasms 3 Sarcoma, Synovial 3 Neurofibrosarcoma 3 Histiocytoma, Malignant Fibrous 3 Sarcoma, Alveolar Soft Part 2 Recurrence 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neuroendocrine Tumors 2 Melanoma 2 Gliosarcoma 2 Glioblastoma 2 Fibrosarcoma 2 Clear-cell metastatic renal cell carcinoma 2 Chondrosarcoma, Extraskeletal Myxoid 2 Carcinoma, Ovarian Epithelial 2 Brain Neoplasms 2

Interventions

Gemcitabine 25 Cisplatin 17 pembrolizumab 6 Capecitabine 5 Fluorouracil 4 durvalumab 3 Taxes 3 Oxaliplatin 3 Carboplatin 3 130-nm albumin-bound paclitaxel 3 tremelimumab 2 trametinib 2 pemigatinib 2 ivosidenib 2 infigratinib 2 derazantinib 2 atezolizumab 2 Radiotherapy 2 Radiosurgery 2 Platinum 2 Nivolumab 2 Liver Transplantation 2 Leucovorin 2 Drug Therapy 2 Albumin-Bound Paclitaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2 vandetanib 1 tucatinib 1 trifluridine tipiracil drug combination 1 tofacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡